Conmed's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics

What is ROE for Conmed in the third quarter 2026?
Conmed Corporation achieved a return on average equity (ROE) of 7.07 % in its third quarter 2026, this is above CNMD's average return on equity of 4.78%.
Conmed Corporation shareholder's equity over the 12 months ending in its third quarter 2026 are valued at $1,038 million

While the company's net income was fading, Conmed was able to improve its ROE compared to the second quarter 2026.

Within the Medical Equipment & Supplies industry 49 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the second quarter 2026 from 1267 to 1944.

What is ROE?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Equity ROE▼

None ▼

Return on Equity ROE▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Equity	(Sep 30 2026) III. Quarter	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter
Y / Y Equity Change	5.12 %	3.84 %	4.1 %	7.31 %	-
Y / Y Net Income Change	592.41 %	7.7 %	129.09 %	-50.41 %	-94.16 %
Net Income (TTM) in Millions	73	56	55	47	64
Return On Equity (TTM)	7.07 %	5.51 %	5.4 %	4.68 %	6.49 %
CNMD's Total Ranking	# 1944	# 1267	# 1474	# 934	#
Equity (TTM) in Millions	1,060	1,041	1,018	1,033	1,008
Seq. Equity Change	1.78 %	2.33 %	-1.49 %	2.46 %	0.54 %
Seq. Net Income Change	-14.2 %	66.84 %	-17.39 %	485.48 %	-86.65 %

Back to CNMD Management Effectiveness >> CNMD's 5 Years Annual ROE >> Compare CNMD ROE to its Competitors

Return On Equity Company Ranking
Within:	No.
Industry	# 50
Sector	# 158
Overall	# 1944

Return On Equity Statistics
High	Average	Low
15.04 %	4.78 %	-15.17 %
(Sep 30 2024)		(Jun 30 2022)

CNMD Annual Return On Equity	(Dec 31 2025) 2025	(Dec 31 2024) 2024	(Dec 31 2023) 2023	(Dec 31 2022) 2022	(Dec 31 2021) 2021
Total Equity in Millions	1,033	963	834	746	785
Y / Y Equity Change	7.31 %	15.4 %	11.89 %	-5.08 %	10.77 %
Net Income in Millions	47	132	64	-81	63
Y / Y Net Income Change	-64.47 %	105.44 %	-	-	557.16 %
Return On Equity	4.55 %	13.76 %	7.73 %	-10.81 %	7.96 %

Back to CNMD Management Effectiveness >> CNMD's 5 Years Annual ROE >> Compare CNMD ROE to its Competitors

Annual Roe Comment

In 2025 ROE decreased compared to the previous year to 4.55 %, due to deterioration of net income.

More Return On Equity Ratios
Medical Equipment & Supplies Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
CNMD's' Return on Equity at Yahoo Finance
CNMD's Roe Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for CNMD's Competitors
Subscribers only: Roe for Conmed's Suppliers
Subscribers only: Return On Equity for CNMD's Customers

Companies with similar Return On Equity at Sep 30 2026, within Healthcare Sector	ROE
Beone Medicines Ltd	18.21 %
Pediatrix Medical Group Inc	17.28 %
Kiniksa Pharmaceuticals International Plc	17.27 %
Krystal Biotech Inc	17.02 %
Intuitive Surgical Inc	16.99 %
Ensign Group Inc	16.62 %
Lemaitre Vascular Inc	15.81 %
Stryker Corp	15.61 %
Quest Diagnostics Inc	15.22 %
Regeneron Pharmaceuticals Inc	15.07 %
Alpha Pro Tech Ltd	14.68 %
Bio rad Laboratories Inc	14.07 %
Boston Scientific Corporation	13.75 %
Inspire Medical Systems inc	12.49 %
Haemonetics Corporation	12.07 %
Labcorp Holdings Inc	11.55 %
Henry Schein Inc	11.29 %
Medinotec Inc	10.97 %
Tactile Systems Technology Inc	10.73 %
Penumbra Inc	10.44 %
Teleflex Incorporated	9.67 %
Merit Medical Systems Inc	9.65 %
U S Physical Therapy Inc	9.48 %
Abbott Laboratories	9.00 %
Lifevantage Corp	8.17 %
Pacific Health Care Organization Inc	8.10 %
Incyte Corporation	7.08 %
Conmed Corporation	7.07 %
Teva Pharmaceutical Industries Limited	6.37 %
Integer Holdings Corporation	6.02 %

Date modified: 2026-10-29T09:59:09+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.